Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Apr 26, 2011
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Shares, no par value
2011-04-21$54.05/sh−235,793$12,744,612→ 5,414,861 total
Footnotes (2)
- [F1]Common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of Long-Term Performance Units.
- [F2]This number represents common shares received upon vesting of Long-Term Performance Units, as well as Restricted Share Units and Long-Term Performance Units that were previously reported in Table I of a Form 4 filed on September 30, 2010.